| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of USP33 mRNA | affects expression | 21346803
|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of USP33 mRNA | affects expression | 21346803
|
| D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of USP33 mRNA | decreases expression | 19150397
|
| D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of USP33 mRNA | affects cotreatment|increases expression | 17183730
|
| D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in decreased expression of USP33 mRNA | affects cotreatment|decreases expression | 19244175
|
| D012643 |
Selenium |
Selenium results in decreased expression of USP33 mRNA | decreases expression | 19244175
|
| C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of USP33 mRNA | affects expression | 17440010
|
| D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of USP33 mRNA | affects cotreatment|increases expression | 17183730
|
| D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in decreased expression of USP33 mRNA | affects cotreatment|decreases expression | 19244175
|
| D014810 |
Vitamin E |
Vitamin E results in decreased expression of USP33 mRNA | decreases expression | 19244175
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.82 | 8875741 |
| MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.17 | 19490988 |
| MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.61 | 17688650 |
| MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.76 | 17497229 |
| MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 19460635 17157402 19232924 17507914 18940202 18316065 17688650 15238991 18177632 20603192 18558336 18775368 16609825 18985861 18396377 |
| MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.18 | 20046352 17594078 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.54 | 8888407 |
| MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.24 | 16050911 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.05 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.05 | 16705839 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.18 | 6135515 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.18 | 20889678 |
| MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.78 | 20734317 |
| MESH:D003092 |
Colitis |
|
Selenium |
4.09 | 17936198 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.77 | 17688650 16575769 8888407 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
2.77 | 19769572 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.94 | 18551238 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.94 | 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
9.51 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
9.51 | 18551238 21346803 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
9.51 | 15131321 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
9.51 | 1733752 19641884 |
| MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.31 | 1851702 |
| MESH:C538011 |
Eales disease |
|
Vitamin E |
5.08 | 9068938 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.46 | 17275665 3659116 |
| MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.29 | 16628512 3922381 |
| MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.04 | 20417680 18234410 |
| MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.80 | 6426943 7562514 6254150 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.60 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.40 | 3659116 |
| MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.12 | 20426865 |
| MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.54 | 14986274 19224547 |
| MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.26 | 16575769 |
| MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.41 | 8888407 18558336 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
3.10 | 16080930 |
| MESH:D006333 |
Heart Failure |
|
Selenium |
3.21 | 17162251 |
| MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.77 | 16863852 16490937 |
| MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
6.12 | 17440010 |
| MESH:D019584 |
Hot Flashes |
|
Vitamin E |
4.35 | 14716179 |
| MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.20 | 17688650 |
| MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.93 | 16612254 |
| MESH:D007251 |
Influenza, Human |
|
Selenium |
12.25 | 16624496 |
| MESH:D007251 |
Influenza, Human |
|
Vitamin E |
12.25 | 16624496 |
| MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
2.93 | 12488133 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
4.13 | 16518626 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
8.04 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
8.04 | 16705839 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.18 | 17596541 16294345 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
1.90 | 16169303 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.22 | 7678174 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.68 | 6135515 2876784 2876786 |
| MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.33 | 16863852 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.64 | 17228818 |
| MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
1.90 | 11062179 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.90 | 15318939 |
| MESH:D008654 |
Mesothelioma |
|
Selenium |
2.87 | 15107826 |
| MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.36 | 18765137 18803445 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.27 | 8888407 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.28 | 17596541 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.50 | 18551238 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.50 | 18551238 7678174 |
| MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.27 | 16359493 8888407 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.66 | 12819281 16049721 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.66 | 16049721 |
| MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.27 | 15087411 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.17 | 20603192 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
3.26 | 15084515 |
| MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.92 | 12752131 11422049 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.44 | 19155313 |
| MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
10.75 | 18551238 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
10.75 | 18551238 |
| MESH:D012640 |
Seizures |
|
Valproic Acid |
10.75 | 11738929 16876388 3137016 11044598 14763951 15475178 17978042 1511512 |
| MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.49 | 18709164 |
| MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.96 | 19490988 |
| MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.92 | 12833885 |
| MESH:D020521 |
Stroke |
|
Vitamin E |
3.71 | 16517955 |
| MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.61 | 17262798 |
| MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.86 | 3119515 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.28 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.28 | 16049721 |
| MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.95 | 8888407 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
13.14 | 10091137 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
13.14 | 10091137 |